FGFR3 and urinary bladder carcinoma: Based on this, Hortelão et al. presented the fibroblast growth factor receptor 3 (FGFR3), targeting antibody-coupled urease-powered nanomotors for active target therapy in bladder cancer spheroids (Figure 15a) [157].